AnalgeSiC and appEtite-stimulating Effects of caNnabigerol and THC (ASCENT)
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Abuse, Drug
- Appetite Loss
- Pain
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: RandomizedIntervention Model: Crossover AssignmentIntervention Model Description: This is a randomized, double-blind, placebo-controlled study. All participants will complete all dose conditions in a randomized order.Masking: Double (Participant, Investigator)Primary Purpose: Basic Science
Participation Requirements
- Age
- Between 21 years and 55 years
- Gender
- Both males and females
Description
The overall aim of this double-blind, placebo-controlled, within-subject study in healthy, occasional cannabis smokers is to ascertain the dose-dependent analgesic and appetite-stimulating effects of ecologically relevant doses of cannabigerol (CBG) alone and in combination with a sub-analgesic / su...
The overall aim of this double-blind, placebo-controlled, within-subject study in healthy, occasional cannabis smokers is to ascertain the dose-dependent analgesic and appetite-stimulating effects of ecologically relevant doses of cannabigerol (CBG) alone and in combination with a sub-analgesic / sub-appetite stimulating, minimally psychoactive dose of THC and an analgesic, appetite-stimulating, but intoxicating dose of THC.
Tracking Information
- NCT #
- NCT04859296
- Collaborators
- Center for Medicinal Cannabis Research
- Investigators
- Principal Investigator: Ziva D Cooper, PhD University of California, Los Angeles
Get Well Soon